Davenport & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.09M Sell
363,522
-107,306
-23% -$1.8M 0.03% 289
2025
Q1
$7.24M Buy
470,828
+89,340
+23% +$1.37M 0.04% 252
2024
Q4
$8.41M Buy
381,488
+13,811
+4% +$304K 0.05% 234
2024
Q3
$6.63M Sell
367,677
-4,981
-1% -$89.8K 0.04% 260
2024
Q2
$6.06M Buy
372,658
+30,991
+9% +$504K 0.04% 264
2024
Q1
$4.82M Buy
+341,667
New +$4.82M 0.03% 301
2022
Q4
Sell
-14,408
Closed -$116K 1019
2022
Q3
$116K Buy
+14,408
New +$116K ﹤0.01% 936
2021
Q4
Sell
-11,972
Closed -$117K 1087
2021
Q3
$117K Sell
11,972
-720
-6% -$7.04K ﹤0.01% 996
2021
Q2
$126K Hold
12,692
﹤0.01% 919
2021
Q1
$146K Buy
12,692
+2,205
+21% +$25.4K ﹤0.01% 769
2020
Q4
$101K Sell
10,487
-2,700
-20% -$26K ﹤0.01% 763
2020
Q3
$119K Sell
13,187
-1,900
-13% -$17.1K ﹤0.01% 701
2020
Q2
$186K Buy
15,087
+3,087
+26% +$38.1K ﹤0.01% 656
2020
Q1
$108K Sell
12,000
-500
-4% -$4.5K ﹤0.01% 620
2019
Q4
$123K Buy
+12,500
New +$123K ﹤0.01% 695
2017
Q4
Sell
-11,536
Closed -$203K 723
2017
Q3
$203K Sell
11,536
-14,270
-55% -$251K ﹤0.01% 627
2017
Q2
$857K Sell
25,806
-157
-0.6% -$5.22K 0.01% 323
2017
Q1
$941K Buy
25,963
+63
+0.2% +$2.28K 0.01% 298
2016
Q4
$938K Sell
25,900
-6,593
-20% -$239K 0.01% 298
2016
Q3
$1.5M Sell
32,493
-666
-2% -$30.6K 0.02% 238
2016
Q2
$1.67M Sell
33,159
-2,697
-8% -$135K 0.03% 222
2016
Q1
$1.92M Sell
35,856
-673,107
-95% -$36M 0.03% 205
2015
Q4
$46.5M Buy
708,963
+12,867
+2% +$845K 0.75% 44
2015
Q3
$39.3M Buy
696,096
+686
+0.1% +$38.7K 0.66% 57
2015
Q2
$41.1M Buy
695,410
+8,122
+1% +$480K 0.64% 57
2015
Q1
$42.8M Buy
687,288
+17,123
+3% +$1.07M 0.66% 49
2014
Q4
$38.5M Sell
670,165
-9,944
-1% -$572K 0.62% 59
2014
Q3
$36.6M Buy
680,109
+6,914
+1% +$372K 0.64% 55
2014
Q2
$35.3M Sell
673,195
-504,129
-43% -$26.4M 0.6% 62
2014
Q1
$62.2M Buy
1,177,324
+24,022
+2% +$1.27M 1.13% 21
2013
Q4
$46.2M Buy
1,153,302
+483,708
+72% +$19.4M 0.86% 32
2013
Q3
$25.3M Buy
669,594
+623,758
+1,361% +$23.6M 0.52% 76
2013
Q2
$1.8M Buy
+45,836
New +$1.8M 0.04% 175